Qb Flu

Drug Profile

Qb Flu

Alternative Names: gH1-Qbeta; H1N1 influenza VLP vaccine - A*STAR/Cytos; Influenza A H1N1 virus-like particle vaccine - A*STAR/Cytos; Influenza-A virus vaccine - Cytos; Qb-Flu; Qb-VLP vaccine; Recombinant flu vaccine - A*STAR/Cytos

Latest Information Update: 27 Feb 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Agency for Science, Technology and Research
  • Developer Agency for Science, Technology and Research; Cytos Biotechnology; Singapore Immunology Network
  • Class Influenza virus vaccines; Virus-like particle vaccines
  • Mechanism of Action B cell stimulants; Helper-inducer T-lymphocyte modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Influenza A virus H1N1 subtype

Most Recent Events

  • 13 May 2014 Qb Flu is available for licensing as of 05 May 2014. http://www.cytos.com
  • 05 May 2014 Suspended - Phase-I for Influenza-A virus H1N1 subtype in Singapore (Parenteral)
  • 29 Jan 2014 Immunogenicity data from a phase I trial in Influenza-A virus H1N1 subtype (prevention, in volunteers) released by Cytos Biotechnology and Agency for Science, Technology and Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top